NUTRITIONAL CARE FOR ADULTS WITH OBESITY TREATED WITH GLUCAGON-LIKE PEPTIDE (GLP)-1 AND DUAL GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP)/GLP-1 RECEPTOR AGONISTS: A REVIEW OF EVIDENCE, GAPS, AND CLINICAL IMPLICATIONS

Descargar Publicación
Current application and future directions for the sarcopenic obesity Global Leadership Initiative (SOGLI) diagnostic algorithm MASH: Primer fármaco enzimático que revierte el daño hepático